P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
Main Authors: | Devillers G, Lopalco L, Mouz N, Amacker M, Roger M, Drillet A, Bomsel M, Zurbriggen R, Fleury S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-10-01
|
Series: | Retrovirology |
Similar Items
-
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.
by: Geert Leroux-Roels, et al.
Published: (2013-01-01) -
SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.
by: Athe M N Tsibris, et al.
Published: (2011-01-01) -
P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques
by: Schuitemaker H, et al.
Published: (2009-10-01) -
P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate
by: Montefiori D, et al.
Published: (2009-10-01) -
Use of immunopotentiating reconstituted influenza virosomes (IRIV) as vector to deliver antigens into dendritic cells
by: Zurbriggen R, et al.
Published: (2004-07-01)